Betsy Foxman1, Ai Wen2, Usha Srinivasan2, Deborah Goldberg3, Carl F Marrs2, John Owen4, Deborah A Wing5, Dawn Misra6. 1. Department of Epidemiology, University of Michigan School of Public Health, Ann Arbor, MI. Electronic address: bfoxman@umich.edu. 2. Department of Epidemiology, University of Michigan School of Public Health, Ann Arbor, MI. 3. Department of Ecology and Evolutionary Biology, University of Michigan Medical School, Ann Arbor, MI. 4. Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, The University of Alabama at Birmingham, Birmingham, AL. 5. Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, University of California at Irvine School of Medicine, Irvine, CA. 6. Department of Family Medicine and Public Health Sciences, School of Medicine, Wayne State University, Detroit, MI.
Abstract
OBJECTIVE: Genital tract infection accounts for approximately 25-40% of all preterm births. We sought to assess the relationship between preterm birth and selected vaginal bacterial taxa associated with preterm birth either directly or through their association with bacterial vaginosis (BV). STUDY DESIGN: Vaginal fluid for Gram stain was collected between 17 and 22 weeks' gestation as part of a randomized trial of ultrasound-indicated cerclage for preterm birth prevention in women at high risk for recurrent spontaneous preterm birth. Bacterial deoxyribonucleic acid was extracted from the Gram stain slides and analyzed using quantitative polymerase chain reaction. RESULTS: Among the 499 participants, Mycoplasma was positively correlated with increased risk of preterm (risk ratio [RR], 1.83; 95% confidence interval [CI], 1.52-2.22) as was Mobiluncus (RR, 1.36; 95% CI, 1.07-1.73) and Atopobium (RR, 1.44; 95% CI, 1.1-1.87). However, there were strong interactions between the race/ethnic group and the presence of these and other individual taxa on risk of preterm birth. By contrast, bacterial vaginosis-associated bacteria (BVAB)-3 was consistently associated with a reduction in the risk of preterm birth for all racial/ethnic groups (0.55; 95% CI, 0.39-0.78). CONCLUSION: BV is characterized by a reduction of Lactobacillus, and lactic acid-producing bacteria and the presence of Mobiluncus; we found these factors and the presence of Mycoplasma to be associated with an increased risk of preterm birth. By contrast, the presence of a recently identified organism sufficient to cause BV, BVAB3, decreased the risk of preterm birth. These findings give insight into why treating BV has mixed impact on risk of preterm birth.
OBJECTIVE:Genital tract infection accounts for approximately 25-40% of all preterm births. We sought to assess the relationship between preterm birth and selected vaginal bacterial taxa associated with preterm birth either directly or through their association with bacterial vaginosis (BV). STUDY DESIGN: Vaginal fluid for Gram stain was collected between 17 and 22 weeks' gestation as part of a randomized trial of ultrasound-indicated cerclage for preterm birth prevention in women at high risk for recurrent spontaneous preterm birth. Bacterial deoxyribonucleic acid was extracted from the Gram stain slides and analyzed using quantitative polymerase chain reaction. RESULTS: Among the 499 participants, Mycoplasma was positively correlated with increased risk of preterm (risk ratio [RR], 1.83; 95% confidence interval [CI], 1.52-2.22) as was Mobiluncus (RR, 1.36; 95% CI, 1.07-1.73) and Atopobium (RR, 1.44; 95% CI, 1.1-1.87). However, there were strong interactions between the race/ethnic group and the presence of these and other individual taxa on risk of preterm birth. By contrast, bacterial vaginosis-associated bacteria (BVAB)-3 was consistently associated with a reduction in the risk of preterm birth for all racial/ethnic groups (0.55; 95% CI, 0.39-0.78). CONCLUSION: BV is characterized by a reduction of Lactobacillus, and lactic acid-producing bacteria and the presence of Mobiluncus; we found these factors and the presence of Mycoplasma to be associated with an increased risk of preterm birth. By contrast, the presence of a recently identified organism sufficient to cause BV, BVAB3, decreased the risk of preterm birth. These findings give insight into why treating BV has mixed impact on risk of preterm birth.
Authors: M A Klebanoff; J C Carey; J C Hauth; S L Hillier; R P Nugent; E A Thom; J M Ernest; R P Heine; R J Wapner; W Trout; A Moawad; K J Leveno; M Miodovnik; B M Sibai; J P Van Dorsten; M P Dombrowski; M J O'Sullivan; M Varner; O Langer; D McNellis; J M Roberts Journal: N Engl J Med Date: 2001-08-16 Impact factor: 91.245
Authors: Betsy Foxman; Shannon D Manning; Patricia Tallman; Richard Bauer; Lixin Zhang; James S Koopman; Brenda Gillespie; Jack D Sobel; Carl F Marrs Journal: Am J Epidemiol Date: 2002-12-15 Impact factor: 4.897
Authors: Geeta Bhat; Morgan R Peltier; Tariq Ali Syed; Cayce O Drobek; George Saade; Ramkumar Menon Journal: Am J Reprod Immunol Date: 2012-12-06 Impact factor: 3.886
Authors: G G Donders; K Van Calsteren; G Bellen; R Reybrouck; T Van den Bosch; I Riphagen; S Van Lierde Journal: BJOG Date: 2009-06-17 Impact factor: 6.531
Authors: Matthew Josiah Allen-Daniels; Myrna G Serrano; Lindsey P Pflugner; Jennifer M Fettweis; Melissa A Prestosa; Vishal N Koparde; J Paul Brooks; Jerome F Strauss; Roberto Romero; Tinnakorn Chaiworapongsa; David A Eschenbach; Gregory A Buck; Kimberly K Jefferson Journal: Am J Obstet Gynecol Date: 2015-01-28 Impact factor: 8.661
Authors: Benjamin J Callahan; Daniel B DiGiulio; Daniela S Aliaga Goltsman; Christine L Sun; Elizabeth K Costello; Pratheepa Jeganathan; Joseph R Biggio; Ronald J Wong; Maurice L Druzin; Gary M Shaw; David K Stevenson; Susan P Holmes; David A Relman Journal: Proc Natl Acad Sci U S A Date: 2017-08-28 Impact factor: 11.205
Authors: Jennifer E Balkus; Sujatha Srinivasan; Omu Anzala; Joshua Kimani; Chloe Andac; Jane Schwebke; David N Fredricks; R Scott McClelland Journal: J Infect Dis Date: 2017-03-01 Impact factor: 5.226
Authors: William A Agger; Danish Siddiqui; Steven D Lovrich; Steven M Callister; Andrew J Borgert; Kenneth W Merkitch; Tina C Mason; Dennis J Baumgardner; James K Burmester; Sanjay K Shukla; Joseph D Welter; Katharina S Stewart; M J Washburn; Howard H Bailey Journal: Obstet Gynecol Date: 2014-11 Impact factor: 7.661
Authors: Michele N Austin; Lorna K Rabe; Sujatha Srinivasan; David N Fredricks; Harold C Wiesenfeld; Sharon L Hillier Journal: Anaerobe Date: 2014-12-04 Impact factor: 3.331
Authors: Abdullah H Baqui; Anne C C Lee; Alain K Koffi; Rasheda Khanam; Dipak K Mitra; Sushil K Dasgupta; Jamal Uddin; Parvez Ahmed; Iftekhar Rafiqullah; Mahmoodur Rahman; Abdul Quaiyum; Emilia H Koumans; Parul Christian; Samir K Saha; Luke C Mullany; Alain Labrique Journal: Acta Obstet Gynecol Scand Date: 2018-11-22 Impact factor: 3.636